Health Care·Biotechnology·$5.5B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.88 | N/A | -2.21% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.88 | N/A | -2.21% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed a cautious optimism about the future. They highlighted the importance of their ongoing projects and investments.
Management emphasized their commitment to advancing their pipeline despite the current challenges.
They acknowledged the ongoing investment in R&D as a priority for future growth.
The earnings report indicates that Scholar Rock is still facing challenges, as reflected in the negative EPS. However, the stock rose by 1.91%, suggesting that investors may be optimistic about the company's long-term potential and ongoing projects. The lack of revenue data and guidance could lead to uncertainty in the near term.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AAON INC
Mar 2, 2026